Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT06764433
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with cervicogenic headache according to ICHD-3 criteria
* Cranial and cervical spine imaging is available
* Number of headache days per month 5 and/or more
* Inadequate benefit from pharmacological treatments or physical therapy methods used
* Volunteer patients who can understand and approve the treatment and the informed consent form and who can comply with the treatment
Exclusion Criteria:
* History of secondary headache other than cervicogenic headache according to ICHD-3 criteria
* Cervical nerve root irritation and/or spinal stenosis symptoms and signs
* Sensory deficit findings in the greater occipital nerve dermatome
* Craniocervical defect or other anatomical abnormality in the target area or nearby the procedure
* Local or systemic infection
* Received nonpharmacological treatment within the last 3 months (physical therapy, botulinum toxin A, acupuncture, ozone, cognitive behavioral therapy, etc.)
* Pregnancy or suspected pregnancy
* Known allergy to local anesthetic drugs
* History of malignancy
* Known organic disease of the brain and spinal cord
* History of cranial/cervical surgery within the last 1 year
* Bleeding-clotting disorder or oral anticoagulant use
* Comorbid disease that may cause headache (uncontrolled hypertension, intracranial lesion, etc.)
* Compliance with treatment and treatment results diseases that may affect the evaluation (psychiatric disorder, dementia, etc.)
* Those who request re-treatment due to the emergence of contralateral pain or other types of pain during the follow-up period after treatment
* Those who do not accept treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06764433
Study Brief:
Protocol Section:
NCT06764433